Cardiovascular Disease Treatment News and Information

What is Cardiovascular Disease? (Definition)

Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. The term “heart disease” is often used interchangeably with the term “cardiovascular disease.” Cardiovascular disease includes coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack). Other CVDs are stroke, heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, heart arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, and venous thrombosis.

See below for updated medical research news and information regarding Cardiovascular Disease including new research, treatments and advancements. 

Latest Cardiovascular Disease News

Artery Disease Treatment Research: New Drug Could Help Prevent Artery Disease in High-risk Patients

(SOURCE: UNIVERSITY OF MISSOURI-COLUMBIA) - A recent study by researchers at the University of Missouri School of Medicine has shown that a protein inhibitor drug prevents these blockages, and could be a new therapeutic approach to prevent heart attack, stroke and other diseases caused by blocked blood vessels. According to the American Heart Association, approximately 2,200 Americans die each day from heart ...
Read More

Malignant Rhabdoid Tumor Research News: Loss of key protein unleashes cascade that culminates in rhabdoid tumor formation

(SOURCE: HARVARD MEDICAL SCHOOL) - Rhabdoid tumors are among the most recalcitrant childhood cancers, and scientists have long sought ways to understand what drives their resilience and makes them impervious to treatment. Now researchers from Harvard Medical School, St. Jude Children’s Research Hospital and elsewhere have uncovered a molecular chain of events that interferes with a key mechanism that regulates cell behavior ...
Read More

Statins Help Prevent Heart Attacks and Strokes in Adults with Cardiovascular Risk According to Trial Study

(OREGON HEALTH & SCIENCE UNIVERSITY) According to a recent press release, cholesterol-lowering drugs help prevent heart attacks and strokes in adults with cardiovascular risk factors such as high cholesterol, high blood pressure, diabetes and smoking, but have not yet had a heart attack or stroke, according to a large-scale analysis of clinical trial data led by the OHSU Pacific Northwest ...
Read More

Jardiance® (empagliflozin) Consistently Reduced Risk of Cardiovascular Death in Adults with Type 2 Diabetes and Cardiovascular Disease in Trial

(PR Newswire) According to a recent press release, new data presented at the American Heart Association Scientific Sessions 2016 showed that Jardiance® (empagliflozin) tablets consistently reduced the risk for cardiovascular death, regardless of the type of cardiovascular disease at baseline, compared with placebo when added to standard of care in adults with type 2 diabetes and established cardiovascular disease ...
Read More

Patients Taking Statins May Survive Longer Following Cardiac Arrest

(AMERICAN HEART ASSOCIATION) According to a recent press release, patients who have been taking statins are likely to survive longer after a cardiac arrest than those who are not taking them, according to research from Taiwan researchers presented during the Resuscitation Science Symposium at the American Heart Association's Scientific Sessions 2016 ...
Read More

Researchers Identify Relationship Between Fatty Liver Disease and Cardiovascular Disease

(BOSTON UNIVERSITY MEDICAL CENTER) According to a recent press release, researchers have shown for the first time, that a bi-directional relationship exists between fatty liver disease and cardiovascular disease. Fatty liver disease can lead to increased cardiovascular disease risk and vice versa ...
Read More

Study Finds Diet Rich in Whole Grains May Significantly Lower the Risk of Cardiovascular Disease

(EurekAlert) According to an article recently published in EurekAlert, a team of researchers from Cleveland Clinic, working in collaboration with Nestlé Research Center, conducted one of the largest controlled studies of its kind on whole grains and concluded that a diet rich in whole grains may significantly lower the risk of cardiovascular disease in overweight and obese adults under the ...
Read More

Biomarkers May be Effective in Predicting Type 2 Diabetes Cardiovascular Risk

( According to new research from the Heart Outcomes Prevention Evaluation (HOPE) study, a panel of ten biomarkers including angiopoietin-like protein 2 and N-terminal pro-B-type natriuretic peptide could possibly be of research value to help identify type 2 diabetes patients with high cardiovascular risk when added to routine clinical risk factors ...
Read More